Single Cell Analysis Market

Becton, Dickinson and Company (US) and Danaher Corporation (US) are leading players in Single-cell Analysis Market

The global single-cell analysis market is projected to reach USD 6.3 billion by 2026 from USD 3.1 billion in 2021, at a CAGR of 15.1% during the forecast period. Growth in the single-cell analysis market can mainly be attributed to factors such as technological advancements in single-cell analysis products, rising prevalence of cancer, increasing R&D in the pharmaceutical & biotechnology industries for complex diseases, growth in stem cell research, and growing focus on personalized medicine. On the other hand, the high cost of single-cell analysis instruments is expected to hinder the market growth to a certain extent.

The global single-cell analysis market is highly consolidated. Key players in the market include Becton, Dickinson and Company (US), Danaher Corporation (US), Merck KGAA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), 10x Genomics (US), Promega Corporation (US), Illumina, Inc. (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies, Inc. (US), Tecan Group Ltd. (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems, Inc. (Italy), bioMérieux SA (France), Oxford Nanopore Technologies (UK), Cytek Biosciences (US), Corning Incorporated (US), Apogee Flow Systems Ltd. (UK), NanoCellect Biomedical (US), Rarecyte Inc (US), and On-chip Biotechnologies Co., Ltd. (Japan). The key players in this market are increasingly focusing on strategic expansions, partnerships, to expand their manufacturing capabilities and increase market presence.

To know about the assumptions considered for the study download the pdf brochure

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture, and sale of a wide range of devices, medical supplies, diagnostic products, and laboratory equipment. The company’s products are used by healthcare institutions, life science companies, clinical laboratories, and the pharmaceutical industry. BD has three major business segments, namely, BD Medical, BD Life Sciences, and BD Interventional. The BD Life Sciences segment is further categorized as Preanalytical Systems, Diagnostic Systems, and Biosciences. The company provides single-cell analysis products through the Biosciences segment.

Danaher Corporation offers a broad range of products in the single-cell analysis market, including flow cytometers, cell counters, mass spectrometers, reagents, and kits. The company adopts the strategies of product launches and acquisitions. Over the years, Danaher has acquired several players operating in the single-cell analysis market, such as Beckmann Coulter and Molecular Devices.

Related Reports:

Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, PCR, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Global Forecast to 2026

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Single Cell Analysis Market Size,  Share & Growth Report
Report Code
BT 4224
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2023 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status